Part 1. THE FUTURE OF SCIENCE IS OURS
James Lyons-Weiler, BA, MS, PhD and Peter A. McCullough, MD, MPH join forces with an army of ethical physicians and scientists to say: No More.
As Founding Editor-in-Chief of Science, Public Health Policy, and the Law, I could not be more pleased with the recent developments and expansion of the scope and participation in the journal. From an expansion to our Editorial Board, which includes many ethical physicians and scientists, to the complete restructuring and reformatting of the community-centered journal website, I foresee a future in which studies, papers, and other correspondences within the pages of this journal secure – forevermore – a forum that not only tolerates but that importantly celebrates both dissenting viewpoints and rational discourse. Independent science means independent.
With the relaunch of this journal, narrative-enforcing “science” is dead. Long live rational, empirical science.
Without this journal, many vital results might never have seen the light of day. These results are worthy of the attention of scientists, physicians, and laypersons. Policymakers will come to learn of the high value of our published papers and studies – and medical boards will find them both easy to understand and highly informative.
We have brought together science and discourse about science in a way that can only work to increase wellness in our species. Gone is the focus on increasing the well-being of pharmaceutical companies’ profits. Gone forever is the influence of censors. Our advertisers will have no say over editorial decisions, and advertisers that attempt to exert influence will be dropped. Calls for retraction will have to follow our process that respects rational discourse.
Our journal will publish manuscripts that survive rigorous peer review in any area of science (yes, any), including but not limited to clinical science, public health, policy, law, ethics, diagnostics, and mind science.
Thus, as it ever should have been.
Science 2.0 is Narrative-Free
Science is a way of knowing, a process that, when followed, tends, more often than not, to bring us closer to understanding reality. When Science is corrupted, it is no longer science, and those conducting fraud—no matter how widespread and thorough—are fraudsters, not scientists. It should go without saying that fraud is not science, but it bears repeating: efforts that mimic science that enforce narratives are fraud; fraud is not science.
By publishing peer-reviewed case studies, case series, reviews, systematic reviews, meta-analyses, and research letters via rational correspondence, we will ensure the safe passage of objectivity through time. Our journal, of course, is not alone in this endeavor, but we are, by choice and by design, unreachable by powers influenced by pharmaceutical companies or other monied interests. Our pages will not be littered with studies that are biased to make products of any kind appear more efficacious or safer than they are.
By creating an Institutional Review Board, IPAK-EDU has also ushered in an era in which those who have the most significant reason to be concerned with the well-being of the state of Science can participate in ensuring its ethical conduct, including oversight that guarantees respect for the rights of human subjects and the protection of patient privacy rights.
Since we can readily, with discipline, discern the difference between fraud and science, the Editorial board and I are dedicated to publishing Science and discourse on the conduct of medicine, public health, and any other domain informed by science. Please take a look at the Instructions to Authors for details on the types of articles and instructions on how to participate.
SUBSCRIPTION INCLUDES MEMBERSHIP IN THE WORLD SOCIETY FOR ETHICAL SCIENCE.
We invite you to subscribe. It is essential for you to participate this way. Your subscription also serves as dues for The World Society for Ethical Science, an international organization dedicated to safeguarding the central tenets of science. Members in good standing receive notices about the advancement of knowledge through science, discounts to participating events, voting rights, the right to run for office, and other benefits. WSES officers have generous term limits, and the society is structured to function inexorably toward knowledge and is buffered against capture. See the Bylaws for more information.
Knowledge is discovered, not created, and narratives play no role in science. As we rebuild science, let us stay focused on learning with and from each other via science and rational discourse. Let others conduct the unsustainable and unethical business of fraud.
We invite scholarly inquiries such as case reports, correspondences, and studies in all areas of science, including those that influence public health, policy formation, and legal considerations.
This initiative would not be possible without major support from The McCullough Foundation, The Westreich Foundation, Physicians and Scientists for Health, Freedom and Democracy (MWGFD), the students of IPAK-EDU, subscribers to Popular Rationalism, supporters of the IPAK/IPAK-EDU PHPI program, and members of the World Society for Ethical Science.
James Lyons-Weiler, BA, MS, PhD
Editor-in-Chief
IPAK/IPAK-EDU LLC
Part 2. THE FUTURE OF SCIENCE ENSURES THAT THE FUTURE OF MEDICINE IS OURS – CLINICAL SECTION EDITOR
Peter A. McCullough, MD, MPH
The last few decades have witnessed the rise of a powerful and controlling Bio-Pharmaceutical Complex, in other words, a working syndicate of non-governmental agencies (World Health Organization, World Economic Forum, Gates Foundation, Rockefeller Foundation, Wellcome Trust, Coalition for Epidemic Preparedness and Innovation, many major academic medical societies, credentialing boards), governmental public health and regulatory agencies (US Food and Drug Administration, Centers for Disease Control, European Medicines Agency, UK Medicines and Healthcare products Regulatory Agency, Therapeutics Goods Administration, Australia, many other regulatory agencies) and bio-pharmaceutical manufacturers. This complex has gained control of academic publishing and the regulatory authorities through paid advertising and fees, consultancies, speakers bureaus, and other “key opinion leader” programs to favor their products and suppress the use of established generic products and over-the-counter agents. During the pandemic, we witnessed the active suppression of early treatment multi-drug protocols, which resulted in lives lost. The same complex has used propaganda, censorship, retraction, and interference with free speech in social media to suppress critical information and analyses on bio-pharmaceutical product safety.
The future of medicine depends upon the publication of unbiased, valid observations, analyses, original studies, and reviews in Science, Public Health Policy, and the Law. Our journal will fill this critical gap in a time when the medical community and patients have lost in the peer-review and publication process. With over 20 years of Editor-in-Chief experience at two major PUBMED-indexed journals, I promise the Journal will be run with the highest degree of editorial integrity, impervious to pressure or influence from the Bio-Pharmaceutical Complex. Every submission will undergo careful review. Comments from reviewers and editors will be in the spirit of improving the manuscript to have the conclusions best supported by the data and analyses presented. We will focus on how the submission handles threats to validity, including the many sources of bias, confounding, internal and external generalizability, reproducibility, and cohesiveness. We anticipate the reader will have an enhanced experience consuming the literature published in the Journal. We fully expect articles published in the Journal to be widely cited as we work towards listing them in multiple indexes with back-citations for those papers that have already been fully published. These include MedLine, PubMed, EMBASE, SCOPUS, EBSCO Publishing’s Electronic Databases, Google Scholar, and SCIRUS. Please join us in this new endeavor as an author, reviewer, and perhaps on our editorial board.
Peter A. McCullough, MD, MPH
Clinical Section Editor
The McCullough Foundation